Blueprint Medicines (BPMC) Insider Trading & Ownership $91.68 +0.74 (+0.81%) (As of 09/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Blueprint Medicines (NASDAQ:BPMC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.21%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)12Amount OfInsider Selling(Last 12 Months)$31.96 M Get BPMC Insider Trade Alerts Want to know when executives and insiders are buying or selling Blueprint Medicines stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BPMC Insider Buying and Selling by Quarter Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Blueprint Medicines Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/5/2024Philina LeeInsiderSell41,913$93.19$3,905,872.47 7/5/2024Debra Durso-BumpusInsiderSell3,850$111.20$428,120.00 7/3/2024Debra Durso-BumpusInsiderSell8,817$111.29$981,243.93 6/28/2024Debra Durso-BumpusInsiderSell333$111.15$37,012.95 6/21/2024Debra Durso-BumpusInsiderSell74,034$104.19$7,713,602.46 6/5/2024Percy H CarterInsiderSell4,000$105.13$420,520.00 Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER…6/3/2024L. Becker HewesInsiderSell4,922$106.43$523,848.46 5/31/2024L. Becker HewesInsiderSell34,108$105.91$3,612,378.28 5/2/2024Ariel HurleyInsiderSell1,834$103.88$190,515.92 5/2/2024Michael LandsittelCFOSell10,000$105.00$1,050,000.00 3/28/2024Michael LandsittelCFOSell5,000$95.00$475,000.00 3/20/2024Jeffrey W AlbersDirectorSell25,073$87.28$2,188,371.44 3/15/2024Michael LandsittelCFOSell13,734$87.78$1,205,570.52 3/7/2024Christina RossiCOOSell6,070$90.69$550,488.30 3/7/2024Jeffrey W AlbersDirectorSell11,033$90.69$1,000,582.77 3/7/2024Kate HavilandCEOSell12,464$90.69$1,130,360.16 3/7/2024L. Becker HewesInsiderSell3,097$90.69$280,866.93 3/7/2024Michael LandsittelCFOSell5,003$90.69$453,722.07 3/7/2024Tracey L MccainEVPSell5,194$90.69$471,043.86 3/4/2024Christopher K MurrayInsiderSell621$93.65$58,156.65 2/28/2024Christopher K MurrayInsiderSell5,000$100.00$500,000.00 1/25/2024Jeffrey W AlbersDirectorSell25,000$81.91$2,047,750.00 12/22/2023Ariel HurleyInsiderSell714$90.00$64,260.00 12/7/2023Christopher K MurrayInsiderSell5,000$75.00$375,000.00 12/4/2023Christopher K MurrayInsiderSell600$71.43$42,858.00 11/30/2023Jeffrey W AlbersDirectorSell5,000$70.55$352,750.00 11/24/2023Jeffrey W AlbersDirectorSell15,000$67.51$1,012,650.00 11/3/2023Jeffrey W AlbersDirectorSell1,485$60.13$89,293.05 11/1/2023Jeffrey W AlbersDirectorSell3,881$60.02$232,937.62 10/26/2023Christopher K MurrayInsiderSell600$56.40$33,840.00 10/4/2023Fouad NamouniInsiderSell3,769$48.06$181,138.14 9/28/2023Jeffrey W AlbersDirectorSell6,898$50.17$346,072.66 (Data available from 1/1/2013 forward) BPMC Insider Trading Activity - Frequently Asked Questions Who is on Blueprint Medicines's Insider Roster? The list of insiders at Blueprint Medicines includes Ariel Hurley, Christina Rossi, Christopher K Murray, Debra Durso-Bumpus, Fouad Namouni, George Demetri, Jeffrey W Albers, Kate Haviland, L. Becker Hewes, Mark Alan Goldberg, Michael Landsittel, Percy H Carter, Philina Lee, and Tracey L Mccain. Learn more on insiders at BPMC. What percentage of Blueprint Medicines stock is owned by insiders? 4.21% of Blueprint Medicines stock is owned by insiders. Learn more on BPMC's insider holdings. Which Blueprint Medicines insiders have been buying company stock? The following insider purchased BPMC shares in the last 24 months: Kate Haviland ($48,378.00). How much insider buying is happening at Blueprint Medicines? Insiders have purchased a total of 1,100 BPMC shares in the last 24 months for a total of $48,378.00 bought. Which Blueprint Medicines insiders have been selling company stock? The following insiders have sold BPMC shares in the last 24 months: Ariel Hurley ($254,775.92), Christina Rossi ($714,305.75), Christopher K Murray ($1,095,504.65), Debra Durso-Bumpus ($9,159,979.34), Fouad Namouni ($415,140.24), Jeffrey W Albers ($9,221,053.85), Kate Haviland ($1,433,741.76), L. Becker Hewes ($4,417,093.67), Michael Landsittel ($3,321,652.35), Percy H Carter ($540,622.42), Philina Lee ($3,905,872.47), and Tracey L Mccain ($622,792.82). How much insider selling is happening at Blueprint Medicines? Insiders have sold a total of 408,060 Blueprint Medicines shares in the last 24 months for a total of $35,102,535.24 sold. Blueprint Medicines Key ExecutivesMs. Kathryn Haviland (Age 48)President, CEO & Director Compensation: $1.17MMr. Alexis A. Borisy A.M. (Age 52)Co-Founder & Director Compensation: $50kMr. Michael Landsittel (Age 52)Chief Financial Officer Compensation: $785.36k2 recent tradesMs. Tracey L. McCain Esq. (Age 56)Executive VP, Chief Legal & Compliance Officer and Secretary Compensation: $764.9kDr. Fouad Namouni M.D. (Age 55)President of Research & Development Compensation: $916.4kMs. Ariel Hurley (Age 50)Senior VP, Finance & Principal Accounting Officer 1 recent tradesDr. Christopher K. Murray Ph.D. (Age 60)Senior VP of Technical Operations and Chief Technical Operations & Quality Officer Compensation: $338.37kDr. Percy H. Carter M.B.A. (Age 53)Ph.D., Chief Scientific Officer Compensation: $761.15kJenna CohenSenior Director & Head of Investor RelationsMs. Debra Durso-Bumpus (Age 54)Chief People Officer 4 recent trades More Insider Trading Tools from MarketBeat Related Companies: CLDX Insider Trading DCPH Insider Trading SDGR Insider Trading EBS Insider Trading INCY Insider Trading TEVA Insider Trading BGNE Insider Trading GMAB Insider Trading SMMT Insider Trading VTRS Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:BPMC) was last updated on 9/22/2024 by MarketBeat.com Staff From Our PartnersJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWall Street Insider Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Blueprint Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
